SEC Tracker
Get the app

Corcept Therapeutics CORT

James N Wilson (Director) plans to sell 30,000 CORT shares, about $3.3M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Sep 15, 2026
  2. Broker: THE CHARLES SCHWAB CORPORATION
  3. Shares acquired by: STOCK OPTION AWARDS
  4. 10b5-1 plan adopted: Mar 17, 2026

All of James N Wilson's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 6,800 shares at $110.27 on Sep 15, 2026 · Form 4
  • Sold 400 shares at $110.84 on Sep 15, 2026 · Form 4
  • Sold 2,800 shares at $111.7 on Sep 15, 2026 · Form 4
  • Sold 6,654 shares at $114.48 on Oct 15, 2026 · Form 4
  • Sold 3,046 shares at $115.39 on Oct 15, 2026 · Form 4
  • Sold 300 shares at $116.3 on Oct 15, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.